Augmented Reality For MRI-Guided Interventions

Overview

About this study

The purpose of this study is to evaluate the MRI-compatible needle guidance system (LUMENA) created by Clearguide Medical and previously tested at Children’s National Hospital in phantom and clinical trial studies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, ages 18-90 years
  • Patient referred to Interventional Radiology for image-guided liver needle placement for ablation/biopsy.

Exclusion Criteria:

  • Patients who are unable to give informed consent themselves or through their parents.
  • Patients that do not fit into MR scanner (70 cm bore) with room for needle placement.
  • Contraindications to MRI such as MR-unsafe implants.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/13/2025. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Woodrum, M.D., Ph.D.

Contact us for the latest status

Contact information:

Desirae Howe-Clayton

(507) 255-0111

Howe.Desirae@mayo.edu

More information

Publications

Publications are currently not available